Michael D. Delost

750 total citations · 1 hit paper
10 papers, 584 citations indexed

About

Michael D. Delost is a scholar working on Organic Chemistry, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Michael D. Delost has authored 10 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 4 papers in Pharmaceutical Science and 2 papers in Molecular Biology. Recurrent topics in Michael D. Delost's work include Synthesis and Catalytic Reactions (6 papers), Catalytic C–H Functionalization Methods (3 papers) and Fluorine in Organic Chemistry (3 papers). Michael D. Delost is often cited by papers focused on Synthesis and Catalytic Reactions (6 papers), Catalytic C–H Functionalization Methods (3 papers) and Fluorine in Organic Chemistry (3 papers). Michael D. Delost collaborates with scholars based in United States. Michael D. Delost's co-authors include Jón T. Njardarson, David T. Smith, Pradipta Das, K. N. Houk, Jeffrey S. Bandar and Kevin A. Scott and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Michael D. Delost

9 papers receiving 577 citations

Hit Papers

From Oxiranes to Oligomers: Architectures of U.S. FDA App... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Delost United States 6 487 111 65 61 37 10 584
T. V. Sravanthi India 4 542 1.1× 100 0.9× 79 1.2× 28 0.5× 29 0.8× 7 623
Scott Boyd United Kingdom 11 664 1.4× 150 1.4× 43 0.7× 56 0.9× 18 0.5× 23 850
Stephen E. Shanahan United Kingdom 8 307 0.6× 114 1.0× 105 1.6× 30 0.5× 16 0.4× 13 422
Geoffroy Sorin France 11 504 1.0× 86 0.8× 53 0.8× 34 0.6× 17 0.5× 26 538
Kerstin Hiesinger Germany 8 431 0.9× 105 0.9× 55 0.8× 29 0.5× 20 0.5× 15 544
Damien Valette United Kingdom 9 521 1.1× 108 1.0× 77 1.2× 18 0.3× 59 1.6× 13 661
Eric M. Woerly United States 10 750 1.5× 169 1.5× 93 1.4× 107 1.8× 15 0.4× 11 844
Brandon R. Smith United States 5 289 0.6× 56 0.5× 50 0.8× 39 0.6× 15 0.4× 5 357
Julia B. Lingnau Germany 11 264 0.5× 153 1.4× 111 1.7× 40 0.7× 23 0.6× 16 442
Vikrant A. Adsool Singapore 11 409 0.8× 86 0.8× 40 0.6× 61 1.0× 8 0.2× 13 482

Countries citing papers authored by Michael D. Delost

Since Specialization
Citations

This map shows the geographic impact of Michael D. Delost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Delost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Delost more than expected).

Fields of papers citing papers by Michael D. Delost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Delost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Delost. The network helps show where Michael D. Delost may publish in the future.

Co-authorship network of co-authors of Michael D. Delost

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Delost. A scholar is included among the top collaborators of Michael D. Delost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Delost. Michael D. Delost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Delost, Michael D., et al.. (2024). Direct Benzylic C−H Etherification Enabled by Base‐Promoted Halogen Transfer. Angewandte Chemie International Edition. 63(39). e202408750–e202408750. 6 indexed citations
2.
Scott, Kevin A., et al.. (2022). Minimalistic graphical presentation approach for total syntheses. Tetrahedron. 126. 133062–133062.
3.
Scott, Kevin A., et al.. (2021). Dienolate Annulation Approach for Assembly of Densely Substituted Aromatic Architectures. The Journal of Organic Chemistry. 86(15). 10555–10567. 5 indexed citations
4.
Das, Pradipta, et al.. (2021). Dramatic Effect of γ-Heteroatom Dienolate Substituents on Counterion Assisted Asymmetric Anionic Amino-Cope Reaction Cascades. Journal of the American Chemical Society. 143(15). 5793–5804. 11 indexed citations
5.
Delost, Michael D.. (2021). Development of New Anionic Cascades and Analysis of US FDA Drug Architectures. UA Campus Repository (The University of Arizona). 1 indexed citations
6.
Delost, Michael D. & Jón T. Njardarson. (2021). Mild Darzens Annulations for the Assembly of Trifluoromethylthiolated (SCF3) Aziridine and Cyclopropane Structures. Organic Letters. 23(15). 6121–6125. 5 indexed citations
7.
Delost, Michael D. & Jón T. Njardarson. (2020). Strategic Vinyl Sulfone Nucleophile β-Substitution Significantly Impacts Selectivity in Vinylogous Darzens and Aza-Darzens Reactions. Organic Letters. 22(17). 6917–6921. 7 indexed citations
8.
Das, Pradipta, et al.. (2018). Asymmetric Vinylogous Aza-Darzens Approach to Vinyl Aziridines. Organic Letters. 20(16). 4942–4945. 14 indexed citations
9.
Delost, Michael D., et al.. (2018). From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Journal of Medicinal Chemistry. 61(24). 10996–11020. 294 indexed citations breakdown →
10.
Das, Pradipta, et al.. (2018). A Survey of the Structures of US FDA Approved Combination Drugs. Journal of Medicinal Chemistry. 62(9). 4265–4311. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026